Antibody tests for identification of current and past infection with SARS-CoV-2-Reference-Cited by-同舟云学术

Antibody tests for identification of current and past infection with SARS-CoV-2

Published:2020-06-25 Issue:6 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Deeks Jonathan J¹²,Dinnes Jacqueline¹²,Takwoingi Yemisi¹²,Davenport Clare¹²,Spijker René³⁴,Taylor-Phillips Sian¹⁵,Adriano Ada¹,Beese Sophie¹,Dretzke Janine¹,Ferrante di Ruffano Lavinia¹,Harris Isobel M¹,Price Malcolm J¹²,Dittrich Sabine⁶,Emperador Devy⁶,Hooft Lotty⁴,Leeflang Mariska MG⁷⁸,Van den Bruel Ann⁹,

Affiliation:

1. Test Evaluation Research Group, Institute of Applied Health Research; University of Birmingham; Birmingham UK

2. NIHR Birmingham Biomedical Research Centre; University Hospitals Birmingham NHS Foundation Trust and University of Birmingham; Birmingham UK

3. Medical Library; Amsterdam UMC, University of Amsterdam, Amsterdam Public Health; Amsterdam Netherlands

4. Cochrane Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University; Utrecht Netherlands

5. Division of Health Sciences, Warwick Medical School; University of Warwick; Coventry UK

6. FIND; Geneva Switzerland

7. Department of Clinical Epidemiology, Biostatistics and Bioinformatics; Amsterdam University Medical Centers, University of Amsterdam; Amsterdam Netherlands

8. Biomarker and Test Evaluation Programme (BiTE); Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands

9. Department of Public Health and Primary Care; KU Leuven; Leuven Belgium

Publisher

Wiley

Subject

Pharmacology (medical)

Reference281 articles.

1. Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays;Adams;medRxiv [Preprint],2020

2. COVID-19 antibody seroprevalence in Santa Clara County, California;Bendavid;medRxiv [Preprint],2020

3. Detection of nucleocapsid antibody to SARS-CoV-2 is more sensitive than antibody to spike protein in COVID-19 patients;Burbelo;MedRxiv [Preprint],2020

4. A peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of corona virus disease 2019 (COVID-19);Cai;MedRxiv [Preprint],2020

5. Performance of VivaDiagTM COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department;Cassaniti;Journal of Medical Virology

Cited by 773 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accuracy of routine laboratory tests to predict mortality and deterioration to severe or critical COVID-19 in people with SARS-CoV-2;Cochrane Database of Systematic Reviews;2024-08-06

2. Assessment of an in-house IgG ELISA targeting SARS-CoV-2 RBD: Applications in infected and vaccinated individuals;Journal of Immunological Methods;2024-07

3. Monitoramento pós-mercado dos testes rápidos para detecção de anticorpos da COVID-19: análise de dados da plataforma Microsoft® Power Bi;Vigilância Sanitária em Debate;2024-06-28

4. Clinical impact of rapid molecular diagnostic tests in patients presenting with viral respiratory symptoms: A systematic literature review;PLOS ONE;2024-06-13

5. Detection of IgG antibodies against the receptor binding domain of the spike protein and nucleocapsid of SARS-CoV-2 at university students from Southern Mexico: a cross-sectional study;BMC Infectious Diseases;2024-06-12